Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 886 of 6351
-
New device aims to cut IV nutrition needs for intestinal failure patients
Disease control CompletedThis project aims to introduce and evaluate a novel assistive prosthetic system that helps prevent and treat nutrient and fluid loss from enterocutaneous fistulas. The device system functions simply to return the output from a fistula back into the distal limb of the intestine.
Sponsor: The Insides Company • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Free stomach infection test and treatment could prevent cancer in at-risk communities
Prevention OngoingH. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive …
Phase 4 • Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
New oral cocktail aims to tame tough leukemia
Disease control Recruiting nowPart 1b of this clinical research study is to find the highest tolerable dose of SNDX-5613 that can be given in combination with ASTX727 (a combination of the drugs decitabine/cedazuridine) and venetoclax for patients with acute myeloid leukemia (AML) or those with a mixed phenot…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New heart pacing strategy could cut defibrillator need
Disease control OngoingThe present study will recruit 50 symptomatic non-ischemic cardiomyopathy (NICM) patients with left ventricular ejection fraction (LVEF) below 35% and complete left bundle branch block (CLBBB), who have not received complete guideline-directed medical therapy (GDMT). Each patient…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail aims to boost immune attack on lung cancer
Disease control OngoingThis study will monitor the safety of novel immunotherapy combinations in participants with Programmed death ligand-1 (PD L-1) high (Tumor cells \[TC\]/ Tumor proportion score \[TPS\] \>= 50%), previously untreated, unresectable, locally advanced or metastatic non-small cell lung…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Inhaled drug could stop deadly lung bleeding in cancer patients
Disease control Recruiting nowThis is a drug study that will examine if inhaled tranexamic acid can improve mortality in patients with cancer-related pulmonary hemorrhage and respiratory failure as compared to usual care.
Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for breast cancer patients: drug may tame Treatment-Linked hot flashes
Symptom relief OngoingResearchers are looking for a better way to treat women with, or at high risk for developing hormone-receptor positive breast cancer, who have vasomotor symptoms (VMS), a condition of having hot flashes caused by anti-cancer therapy. VMS, also called hot flashes, are very common…
Phase 3 • Sponsor: Bayer • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Can writing and performing your own song quiet the voices of schizophrenia?
Symptom relief CompletedThe overarching aim of the proposed work is to align a promising treatment lead - Musical Intervention (MI) - with a promising mechanistic account of psychosis - Predictive Processing. This protocol focuses on the R33 phase, to optimize its administration (Is active participation…
Sponsor: Yale University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can ketamine keep suicidal depression at bay? new trial aims to find out
Disease control Recruiting nowThe study will consist of a 24-week-long trial examining outcomes in patients with Major Depressive Disorder and suicidal ideation who will receive intravenous (IV) ketamine and intranasal (IN) esketamine, compared to a large sample of matched historical controls. Patients will b…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
One shot to restore hearing? new drug takes on steroids
Disease control OngoingThe purpose of this Phase 2 clinical trial is to evaluate the safety, tolerability and efficacy of AC102 administered as single intratympanic injection compared to oral steroid treatment in patients with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL).
Phase 2 • Sponsor: AudioCure Pharma GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug combo targets Hard-to-Treat cancers with KRAS mutation
Disease control OngoingThis is a phase 1b/II, open-label study to evaluate the safety, tolerability, pharmacokinetics and antitumor activities of D-1553 in combination with IN10018 in subjects with locally advanced or metastatic solid tumor with KRAS G12C mutation.
Phase 1/2 • Sponsor: InxMed (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Daily pill aims to improve bladder function in children with spinal conditions
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC
Phase 2/3 • Sponsor: Urovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain injection aims to slow Huntington's
Disease control OngoingA Phase I/II Dose-Finding Study to Evaluate Striatal Administration of AB-1001 (previously BV-101) in Adults with Early Manifest Huntington's Disease
Phase 1/2 • Sponsor: AskBio France, SAS, a subsidiary of AskBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New pill targets MYC cancers in early trial
Disease control OngoingThis Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), high-grade neuroendocrine cancer of any primary site, diffuse large B-cell lymphoma (…
Phase 1/2 • Sponsor: Monte Rosa Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New combo therapy shows promise for Steroid-Resistant ITP
Disease control CompletedA Prospective, Randomized, Open-Label, Multicenter Clinical Trial study to compare the efficacy and safety of ATRA plus eltrombopag compared to eltrombopag monotherapy in the treatment of steroid-resistant/relapsed immune thrombocytopenia (ITP).
Phase 3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:57 UTC
-
New combo aims to tame Chemo's worst side effect in deadly lung cancer
Disease control Recruiting nowLung cancer is by far the leading cause of cancer death among both men and women worldwide and the second most common cancer in terms of new cases. Small cell lung cancer (SCLC) is the deadliest form of lung cancer. The standard first-line treatment is the combination of carbopla…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a diabetes drug tame asthma in obesity? new trial investigates
Disease control OngoingThis is a randomized placebo-controlled trial of semaglutide, an FDA-approved therapy for the treatment of type 2 diabetes mellitus and obesity, in adults with symptomatic asthma despite the use of inhaled steroids and with excess body weight. This study will test the central hyp…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill aims to tame ulcerative colitis Flare-Ups
Disease control CompletedThis is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of …
Phase 3 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could an immunotherapy drug keep kidney cancer from returning after surgery?
Disease control OngoingThe goal of this clinical trial is to learn if the drug toripalimab (an anti-PD-1 antibody) works to prevent cancer recurrence in patients with high-risk renal cell carcinoma after they have had surgery to remove the kidney (nephrectomy). The study will also learn about the safet…
Phase 2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Monkeypox drug trial: can tecovirimat speed up healing?
Disease control CompletedThe purpose of this study is to find out if tecovirimat is a safe and effective drug to treat monkeypox (mpox) in combination with standard of care (SOC). Participants will be randomly assigned to receive oral tecovirimat plus SOC or placebo plus SOC for 14 days.
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC